The short answer: three workflows, not one
After five years of managing procurement for a mid-size diagnostics lab, I stopped treating medical equipment as a single category. Beckman Coulter lab equipment follows a capital-equipment workflow, wound care products follow a consumables workflow, and patient lifts plus oxygen flowmeters follow a third path that hinges almost entirely on documentation and training. Mixing them into one "medical supplies" RFP is how you end up with a rejected invoice and a nursing staff that can't calibrate a flowmeter.
What I mean is that the vendor relationship, the due-diligence checklist, and even the PO template should change depending on which of these three buckets the item falls into. That sounds obvious. It took me two years and one embarrassing return to actually do it.
Who I am, and why this matters
I'm the office administrator for a 180-person clinical diagnostics company. I manage all equipment and supply ordering—roughly $1.6 million annually across 14 vendors—and I report to both operations and finance. When I took over purchasing in 2020, we had one "medical equipment" PO template, one preferred vendor list, and no distinction between a $60,000 chemistry analyzer and a $40 box of wound dressings.
In 2022, a lab manager asked me to source a patient lift and two oxygen flowmeters. I routed them through our standard medical device vendor—the same one we used for Beckman Coulter accessories. The flowmeters arrived without calibration instructions. The patient lift arrived without a sling sizing guide. The lab manager was polite, but I could tell I'd made her job harder. Finance, meanwhile, flagged the flowmeter invoice because the line item said "respiratory accessories" and our PO said "patient handling equipment."
That was the moment I stopped lumping everything together. Now I run three separate workflows. Here's how each one works, and where I still get it wrong.
Workflow one: Beckman Coulter and capital analyzers
Beckman Coulter lab equipment—chemistry analyzers, hematology instruments, centrifuges, flow cytometers, the coagulation line—belongs in the capital equipment workflow. That means multi-year budget planning, service contracts negotiated at the point of sale, and a direct vendor relationship rather than e-commerce.
What I care about here isn't the sticker price. It's documentation and aftermarket support. Beckman Coulter's manuals and parts availability are the reason we've kept our chemistry line with them since before I started. When a reagent probe fails at 11 pm, I need a part number, not a sales rep's voicemail. Their life sciences automation category—the NGS sample prep side—operates on the same principle: you're buying into a documentation ecosystem, not just an instrument.
Here's a trap I see other admin buyers fall into. Beckman Coulter, like most major vendors, has an e-commerce category for consumables and accessories. That does not mean you should buy their instruments like you buy their reagents. A flow cytometer sourced online without a service agreement is a very expensive paperweight. I'm not an instrumentation engineer, so I can't speak to the technical service requirements. What I can tell you from a procurement perspective is that for capital equipment, the contract terms matter as much as the unit price—and the e-commerce workflow doesn't surface those terms.
Workflow two: wound care products and consumables
Wound care products—dressings, cleansers, bandages—are the opposite case. High volume, predictable demand, price-sensitive. The right channel is medical e-commerce, not a direct manufacturer relationship. The "always buy direct" advice ignores the transaction cost of managing 30+ SKU-level suppliers and the value of a single invoice.
What I do: one preferred e-commerce vendor for wound care, reviewed quarterly for pricing and stock reliability. The main risk isn't price—it's formulary creep. If I'm not careful, we end up with four hydrocellular dressing brands because different clinical staff prefer different products. So I buy to a standard list, with exceptions only when the wound care nurse documents a clinical need.
Is that the cheapest option? Honestly, no. A direct manufacturer account might save 6-8% on volume. But I'd spend that savings in time reconciling multiple invoices. This worked for us, but our demand is fairly stable. If you're a wound clinic with seasonal volume swings, the calculus might be different.
Workflow three: patient lifts and oxygen flowmeters
This is the category that bit me. Patient lifts and oxygen flowmeters are assistive devices—lower cost than capital analyzers, but with higher training stakes. The procurement question isn't "which vendor has the lowest unit price." It's "which vendor includes usable documentation and training support."
For the oxygen flowmeter, the "how to use" question is the whole ballgame. I'm not a respiratory therapist, so I can't speak to clinical oxygen titration—that's outside my lane. What I can tell you from a procurement perspective is that the flowmeter purchase should include three things: a calibration guide in the box (not a QR code to a generic manual), confirmation that the flow-rate specs match what the clinical team ordered, and a named contact for replacement parts. Speed, spec accuracy, documentation. In that order.
The classic procurement shortcut—buy the cheapest flowmeter and let the clinical team figure it out—is the "always compare unit prices" advice ignoring training cost. A $180 flowmeter with clear instructions and a calibration log template is worth more than a $120 model that arrives as a bare box. That's not a hypothetical. That's the return I processed in 2022.
Patient lifts add a sizing and sling-compatibility dimension. I now require the vendor to confirm sling compatibility in writing before I issue a PO. It's a 10-minute email that has saved us at least two returns.
I can only speak to our setup—a lab with a small patient-handling support area. If you're outfitting a full hospital ward, the due-diligence requirements will be heavier than anything I've described, and you probably have a biomedical engineering team that I don't.
Where this approach breaks down
Three caveats, and then I'll stop.
First, some facilities genuinely need a consolidated medical supplier for administrative simplicity. If you're a 12-person clinic where the practice manager is also the buyer, one distributor for all four categories might be the right call—even if it's not the cheapest or best-documented option. My three-workflow approach assumes enough volume to justify multiple vendor relationships. Your mileage may vary.
Second, the life sciences e-commerce category is moving fast. As of early 2025, Beckman Coulter and other vendors are pushing more of their catalog online, and the line between "capital equipment" and "consumable" is blurring at the edges. What was best practice in 2020 may not apply in 2025. I re-check my category assumptions annually now, not once every three years. The fundamentals haven't changed—you still need documentation, a service contact, and a clean PO—but the execution has transformed.
Third—and this is the one I'd underline—I'm not a lab manager, a respiratory therapist, or a biomedical engineer. I can tell you how to structure the purchase, verify documentation, and keep finance from rejecting the invoice. I can't tell you which hematology analyzer matches your assay menu or how to titrate oxygen. For that, you need your clinical team in the room before you issue the PO.
Honestly, that last point is the one I wish I'd internalized in 2020. The procurement workflow is the easy part. Knowing what to buy is someone else's call.
